PsychoGenics has exceptional capabilities and experience in preclinical epilepsy research. This neurological disorder is characterized by recurrent and unpredictable seizures, presenting a significant medical challenge to millions worldwide. We are committed to understanding the underlying causes of this complex disorder and optimizing the potential of your novel treatment to bring relief to those in need.

Our Preclinical Epilepsy Research Capabilities

PsychoGenics utilizes preclinical models that correspond with clinical conditions. Our EEG scientists have deep expertise in epilepsy research. With our expertise, we can capture and analyze EEG events from aberrant spiking and absence-like seizures through focal and fully generalized seizures, in order to comprehensively evaluate the therapeutic value of your anti-epileptic treatment.

Insights into Temporal Lobe Epilepsy

Among refractory models, we employ the intrahippocampal kainite mouse model of mesial temporal lobe epilepsy (MTLE).

Exploring Protein Mechanisms in Epilepsy

PsychoGenics offers a comprehensive approach to investigate protein mechanisms in preclinical epilepsy studies. Our expertise in bioanalysis allows us to monitor protein levels and post-translational modifications, providing insights into the mechanism of action for potential drug candidates. Through precise analysis and normalization techniques, we can evaluate protein abundance, contributing to a deeper understanding of the intricate molecular pathways underlying epileptic conditions.

Delivering Quality Studies to Advance Your Epilepsy Research Program

PsychoGenics stands at the forefront of preclinical epilepsy research, leveraging our unparalleled expertise in EEG studies, comprehensive assessments, and innovative preclinical models. With our state-of-the-art capabilities and dedication to scientific excellence, we are poised to drive your efforts and enhance the quality of life for individuals living with epilepsy.

Partner with us and transform your program


Get Started